Zwitterionic Polyurethane Nanofibers for Islet Encapsulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current encapsulation devices for islet transplantation in Type 1 diabetes suffer from mechanical weakness, limited mass delivery, and fibrotic growth, posing safety concerns and hindering long-term functionality and retrieval.

Innovation Solution

Development of zwitterionic polyurethane (ZPU) nanofibrous membranes with a hydrophilic and mechanically robust structure, fabricated through electrospinning, which prevents cell escape and minimizes fibrotic deposition, ensuring long-term biocompatibility and therapeutic efficacy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If hydrogel-based macroscopic devices such as alginate and PEG are used, then biocompatibility and high diffusion rates are achieved, but mechanical strength becomes relatively low

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidmechanical strength
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The invention uses composite materials by combining zwitterionic polymers with polyurethane matrix, creating a material that simultaneously achieves high biocompatibility (from zwitterionic groups) and mechanical strength (from polyurethane backbone), resolving the contradiction between softness and structural integrity

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The invention changes the chemical composition parameters of the polymer material by incorporating zwitterionic moieties (containing both positive and negative charges) into the polyurethane structure, which fundamentally alters the material properties to achieve both mechanical robustness and biological compatibility

Inventive Principle:
Principle #35Parameter changes

2Strength

If hydrophobic macroscopic devices made of PTFE or PCL are used, then mechanical robustness and cell escape prevention are achieved, but fibrotic growth around devices occurs

Engineering Contradiction:
Improvemechanical robustnessVSAvoidfibrotic growth
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The invention changes the surface chemical properties from hydrophobic to hydrophilic by incorporating zwitterionic groups, which fundamentally alters the biological response to prevent fibrotic encapsulation while maintaining mechanical strength through the polyurethane framework

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention converts the typically harmful fibrotic response into a beneficial outcome by using zwitterionic surface chemistry that actively prevents fibrosis, transforming the device-biointerface interaction from harmful encapsulation to beneficial biocompatibility

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Strength

If polyurethane is used for islet encapsulation, then mechanical strength is achieved, but mass delivery is constrained due to hydrophobic nature

Engineering Contradiction:
Improvemechanical strengthVSAvoidmass delivery
Core Design Contradiction:
StrengthVSQuantity of substance

Solution Approach 1:

The invention changes the hydrophobicity parameter of polyurethane by incorporating zwitterionic groups, transforming it from a hydrophobic material with limited mass transport to a hydrophilic material with enhanced diffusion rates for glucose and insulin while retaining mechanical properties

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The ZPU membranes provide adequate mass delivery, antifouling properties, and maintain mechanical robustness, enabling safe and functional islet encapsulation for up to 3 months in diabetic mice, with minimal cellular deposition and effective glucose-stimulated insulin secretion.

Implementation Method 1

high diffusion rates

Methodology Applied
Scientific EffectDiffusion: Diffusion

Implementation Method 2

fabricated through electrospinning

Methodology Applied
Scientific EffectElectrospinning: Electrohydrodynamics

Data Source

PatentUS12559867B2Fibers of polymers that have a backbone including a positively charged component of a zwitterionic moiety, and their use in implantable therapeutic delivery systems
Publication Date: 2026.02.24 CORNELL UNIVERSITY
  • US12559867B2 patent drawing
  • US12559867B2 patent drawing
  • US12559867B2 patent drawing

AI summary

The present application relates to fibers having a diameter of 1 nm to 10,000 nm, of one or more biocompatible polymers, wherein the polymers have a backbone which includes a positively charged component from a zwitterionic moiety. Additionally, this application discloses an implantable therapeutic delivery system and its method of formation, comprising a housing defining a chamber, wherein said housing is porous and formed from the fibers. Inside of the housing includes a preparation of cells which release a therapeutic agent from the chamber. The implantable therapeutic delivery system can be used in the treatment of diabetes.